These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 20037485)

  • 1. Synergistic action of doxorubicin and sulindac in human cervix carcinoma cells - studies on possible mechanisms.
    Gruber BM; Bubko I; Krzyszton-Russjan J; Anuszewska EL
    Med Sci Monit; 2010 Jan; 16(1):BR45-51. PubMed ID: 20037485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible role of HSP60 in synergistic action of anthracyclines and sulindac in HeLa cells.
    Gruber BM; Krzysztoń-Russjan J; Bubko I; Anuszewska EL
    Acta Pol Pharm; 2010; 67(6):620-4. PubMed ID: 21229877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of apoptosis protein profiles--role of P-gp in HeLa cells exposed to doxorubicin.
    Gruber BM; Krzysztoń-Russjan J; Bubko I; Koronkiewicz M; Anuszewska EL
    Cancer Genomics Proteomics; 2012; 9(3):153-61. PubMed ID: 22593250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptosis induction and enhancement of cytotoxicity of anticancer drugs by celecoxib, a selective cyclooxygenase-2 inhibitor, in human head and neck carcinoma cell lines.
    Hashitani S; Urade M; Nishimura N; Maeda T; Takaoka K; Noguchi K; Sakurai K
    Int J Oncol; 2003 Sep; 23(3):665-72. PubMed ID: 12888902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and characterization of P-glycoprotein 1 (Pgp1, ABCB1)-mediated doxorubicin-resistant PLHC-1 hepatoma fish cell line.
    Zaja R; Caminada D; Loncar J; Fent K; Smital T
    Toxicol Appl Pharmacol; 2008 Mar; 227(2):207-18. PubMed ID: 18076962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pluronic block copolymers alter apoptotic signal transduction of doxorubicin in drug-resistant cancer cells.
    Minko T; Batrakova EV; Li S; Li Y; Pakunlu RI; Alakhov VY; Kabanov AV
    J Control Release; 2005 Jul; 105(3):269-78. PubMed ID: 15939500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of p-glycoprotein-mediated multidrug resistance by CJX1, an amlodipine derivative, in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells.
    Ji BS; He L; Liu GQ
    Life Sci; 2005 Sep; 77(18):2221-32. PubMed ID: 15967469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Somatostatin enhanced anti-tumor effect of doxorubicin on gallbladder cancer cells through the regulation of intracellular drug concentration].
    Gong W; Qin YY; Li SG; Quan ZW; Li JY; Zhuang PY; Wan ZW
    Zhonghua Yi Xue Za Zhi; 2010 Oct; 90(38):2718-22. PubMed ID: 21162905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of monensin liposomes on the cytotoxicity, apoptosis and expression of multidrug resistance genes in doxorubicin-resistant human breast tumour (MCF-7/dox) cell-line.
    Shaik MS; Chatterjee A; Singh M
    J Pharm Pharmacol; 2004 Jul; 56(7):899-907. PubMed ID: 15233869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
    Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
    Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulindac induces specific degradation of the HPV oncoprotein E7 and causes growth arrest and apoptosis in cervical carcinoma cells.
    Karl T; Seibert N; Stöhr M; Osswald H; Rösl F; Finzer P
    Cancer Lett; 2007 Jan; 245(1-2):103-11. PubMed ID: 16488075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bcl-2 and mdr-1 gene expression during doxorubicin-induced apoptosis in murine leukemic P388 and P388/R84 cells.
    Ramachandran C; You W; Krishan A
    Anticancer Res; 1997; 17(5A):3369-76. PubMed ID: 9413174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medicarpin and millepurpan, two flavonoids isolated from Medicago sativa, induce apoptosis and overcome multidrug resistance in leukemia P388 cells.
    Gatouillat G; Magid AA; Bertin E; El btaouri H; Morjani H; Lavaud C; Madoulet C
    Phytomedicine; 2015 Dec; 22(13):1186-94. PubMed ID: 26598918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene modulation by the cyclooxygenase inhibitor, sulindac sulfide, in human colorectal carcinoma cells: possible link to apoptosis.
    Bottone FG; Martinez JM; Collins JB; Afshari CA; Eling TE
    J Biol Chem; 2003 Jul; 278(28):25790-801. PubMed ID: 12734198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased anti-tumour efficacy of doxorubicin when combined with sulindac in a xenograft model of an MRP-1-positive human lung cancer.
    O'Connor R; Heenan M; Connolly L; Larkin A; Clynes M
    Anticancer Res; 2004; 24(2A):457-64. PubMed ID: 15152944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of glutathione-related genes, enzyme activities and transport proteins in human cervical cancer cells treated with doxorubicin.
    Drozd E; Krzysztoń-Russjan J; Marczewska J; Drozd J; Bubko I; Bielak M; Lubelska K; Wiktorska K; Chilmonczyk Z; Anuszewska E; Gruber-Bzura B
    Biomed Pharmacother; 2016 Oct; 83():397-406. PubMed ID: 27424321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parthenolide reverses doxorubicin resistance in human lung carcinoma A549 cells by attenuating NF-κB activation and HSP70 up-regulation.
    Xin Y; Yin F; Qi S; Shen L; Xu Y; Luo L; Lan L; Yin Z
    Toxicol Lett; 2013 Aug; 221(2):73-82. PubMed ID: 23792430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-steroidal anti-inflammatory drug activated gene (NAG-1) expression is closely related to death receptor-4 and -5 induction, which may explain sulindac sulfide induced gastric cancer cell apoptosis.
    Jang TJ; Kang HJ; Kim JR; Yang CH
    Carcinogenesis; 2004 Oct; 25(10):1853-8. PubMed ID: 15180942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of correlation of MRP and gamma-glutamylcysteine synthetase overexpression with doxorubicin resistance due to increased apoptosis in SV40 large T-antigen-transformed human mesothelial cells.
    Ogretmen B; Bahadori H; McCauley M; Boylan A; Green M; Safa AR
    Cancer Chemother Pharmacol; 1998; 42(6):441-6. PubMed ID: 9788569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of P-glycoprotein and increasing of drug-sensitivity of a human carcinoma cell line (KB-A-1) by an antisense oligodeoxynucleotide-doxorubicin conjugate in vitro.
    Ren Y; Wei D; Zhan X
    Biotechnol Appl Biochem; 2005 Apr; 41(Pt 2):137-43. PubMed ID: 15202936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.